Eli Lilly and Co
Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly
We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly. Source
Read More
2 takeaways from our daily meeting: What’s behind the bounce and Club stocks in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market gets an oversold bounce Quick Club mentions: AAPL, LLY, EL 1. Market gets an oversold bounce U.S. stocks recovered after falling earlier Wednesday. Treasury yields pulled back from their highs and […]
Read More
2 takeaways from Thursday’s ‘Morning Meeting’: We want to buy on market weakness
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We have no choice but to buy Quick mentions: MRVL, LLY, NVDA, META 1. We have no choice but to buy Stocks slumped on Thursday, continuing their losing streak after […]
Read More
Shares earning the biggest moves premarket: Accenture, Darden Places to eat, household builders and a lot more
In this report DRI CSA-FF SCS CRM KBH LEN Observe your preferred sharesGenerate Free ACCOUNT observe now Movie1:4201:42 News Update – Pre-Markets Information Briefing Examine out the companies making headlines prior to the bell: Accenture (ACN) – The consulting company reported a far better-than-anticipated quarterly revenue and income, but gave a weaker-than-predicted income forecast for […]
Read More
3 takeaways from Monday’s meeting: Market needs a break to rise, some possible buys
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. The market needs a break to bottom Why Jim’s investing in the two-year Treasury Quick mentions: JNJ, LLY, AMZN, QCOM , DHR 1. The market needs a break to bottom […]
Read More
Here’s how we’re positioned in four sectors and some of the stocks we like in each
CNBC’s Jim Cramer gave investors advice on how to build a strong portfolio during the Federal Reserve’s struggle to reduce inflation. Source
Read More
Eli Lilly’s obesity medication looks poised to become a $100 billion a year drug
Bank of America expects Eli Lilly’s Mounjaro could generate as much as $100 billion in annual sales by 2035, if it’s approved to treat obesity and several other illnesses. The Food and Drug Administration granted approval in May to the once-weekly injection for the treatment of Type 2 diabetes. However, the company is actively looking […]
Read More
3 takeaways from the Investing Club’s ‘Morning Meeting’ on Wednesday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Stocks are up – for now We’re fans of Starbucks incoming CEO Quick mentions: LLY, MRVL, BHC 1. Stocks are up – for now Wall Street recovered Wednesday after earlier […]
Read More
4 takeaways from the Investing Club’s ‘Morning Meeting’ on Tuesday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments: Oscillator says market still oversold Our trades on DVN and CRM Quick mentions: HON and LLY Watching these bullpen stocks 1. Oscillator says market still oversold Stocks were in the […]
Read More
Below are Morgan Stanley’s preferred shares for the subsequent 12 months
If you might be seeking for shares to invest in and keep about the upcoming yr, Morgan Stanley has compiled their list of favorites. The bank’s “vintage values” checklist is compiled of names, mainly mid- to big-caps, that Morgan Stanley Investigate thinks are poised to recognize outstanding threat-altered returns more than the upcoming 12 months. […]
Read More